TMO
Thermo Fisher Scientific Inc
676.80$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.5% | 16.6% | 17.3% | 19.1% | 18.7% | 19.5% | 25.7% | 24.3% | 20.4% | 19.6% | 20.2% | 17.5% | |
| 10.0% | 10.0% | 9.6% | 9.7% | 9.3% | 8.9% | 7.2% | 6.6% | 7.5% | 7.9% | 7.2% | 6.2% | |
| 0.7% | 0.7% | 0.7% | 0.8% | 0.7% | 0.7% | 0.6% | 0.6% | 0.7% | 0.6% | 0.7% | 0.7% | |
| -7.0% | -2.6% | -2.4% | -4.5% | -0.8% | -1.5% | -0.3% | 2.0% | -0.4% | – | – | – | |
| 1.7% | -2.7% | -1.4% | 2.3% | -2.2% | -2.4% | -1.2% | -4.0% | -2.3% | -1.3% | -0.8% | -4.0% | |
| 2.5% | 2.5% | 2.4% | 2.4% | 3.1% | 3.6% | 4.6% | 6.4% | 5.0% | 3.5% | 3.3% | 3.4% | |
| -69.8% | -6.4% | -30.3% | -36.9% | -5.1% | -5.8% | -4.7% | -55.9% | -4.8% | -12.0% | -13.6% | -9.1% | |
| 1.4% | 1.4% | 1.3% | 1.1% | 1.1% | 1.2% | 1.0% | 1.0% | 1.0% | 1.2% | 1.4% | 1.4% | |
| 40.0% | -2.9% | -6.8% | -3.6% | -2.1% | -5.9% | -4.7% | -5.1% | -6.7% | -7.0% | -9.3% | -6.7% | |
| 11.1% | -11.4% | 22.8% | 14.5% | -6.4% | -5.5% | 8.5% | 22.7% | 1.5% | -0.4% | -5.6% | 12.0% | |
| 28.4% | -15.4% | 15.7% | 18.4% | -9.2% | -12.2% | 3.0% | 16.8% | -6.3% | -8.5% | -15.8% | 4.0% | |
| -26.5% | -5.3% | 1.8% | 2.6% | 3.1% | 1.2% | 24.6% | -14.9% | 9.0% | -1.0% | -9.5% | 13.1% | |
| 13.0% | 14.1% | 14.8% | 16.7% | 15.5% | 15.8% | 21.2% | 17.9% | 15.4% | 16.2% | 16.9% | 14.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.